Drug recall
Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis…
FDA recall event 81326 · Class II · Teva Pharmaceuticals USA
Key facts
| Event ID | 81326 |
|---|---|
| Recall numbers | D-0129-2019 |
| Recalling firm | Teva Pharmaceuticals USA |
| Product type | Drugs |
| Products | Metoprolol Succinate Extended Release Tablets, USP 50 mg, 100-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing. |
| Initiation date | Oct 19, 2018 |
| Report date | Oct 31, 2018 |
| Termination date | Apr 3, 2019 |
| City | North Wales |
| State | PA |
| Country | United States |
| FEI number | 3003092769 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: